# Post-open Agentic portfolio scan — 2026-08-12

- Decision timestamp: 2026-08-12 13:57 UTC / 09:57 ET
- Main live quote snapshot: about 13:55 UTC / 09:55 ET
- Account: Robinhood Agentic ending 1041 only
- Policy: `playbook/autonomous-policy.md` (ACTIVE)
- Decision: **NO TRADE — hold all five positions; review/place/cancel nothing.**

## Broker and policy state

- Account verified active, cash, Individual, and `agentic_allowed=true`; kill switch clear because value remained far above $10.
- Portfolio at the decision snapshot: **$333.68480469 total**, **$327.47480469 equities**, and **$6.21 cash/buying power**. No options, futures, crypto, or event-contract exposure was used.
- Open-ish equity orders were checked independently: `new=0`, `queued=0`, `confirmed=0`, `unconfirmed=0`, `partially_filled=0`. Pending-order commitment was therefore $0.
- Available-liquid-balance rule: 80% deployable = **$4.968 (~$4.97)**; 20% reserve = **$1.242 (~$1.24)**. Existing exposure counts separately. The book already contained five holdings, so policy prohibited adding a sixth and prohibited recursively spending the reserve.
- Equity deployment at the snapshot was **98.14%** of total value; cash buffer was **1.86%** of total value. This is not an instruction to sell solely to manufacture a 20% portfolio-level cash allocation: the policy's 80/20 rule applies to available liquid buying power after pending orders.
- Broker/account/risk state was sufficiently certain for management. No stop was widened and no averaging down was authorized.

## Market regime and catalysts

Classification: **mixed/risk-on rotation, reduced-size posture**.

- Live tape: SPY $772.45 (+0.25%), QQQ $724.64 (+0.86%), IWM $302.31 (+0.44%). SPY remained above SMA20 $752.30 and SMA50 $747.84; QQQ was above SMA20 $700.73 and SMA50 $713.88; IWM was above SMA20 $295.42 and SMA50 $294.24.
- Leadership was narrow: XLK +1.47% and XLI +0.46%, while XLF -0.19%, XLE -0.21%, XLY -0.86%, and XLV -0.51%. Broad indexes were constructive, but sector disagreement and CPI-day price discovery prevented a clean all-sector risk-on classification.
- CPI was the scheduled macro catalyst. The accessible pre-release consensus expected headline 3.4% YoY / 0.1% MoM and core 2.5% YoY / 0.2% MoM. Exact released July CPI was not asserted because an authoritative release value was not verified during this scan; live tape was treated as the market response.
- AI/semiconductor momentum was the strongest live flow: NVDA +2.34%, AVGO +1.31%, and XLK +1.47%. Financial and energy ETFs did not confirm that strength intraday.

## Existing holdings — ranked management decision

Scores use the eight policy dimensions (0–2 each): regime, sector relative strength, 20/60-day momentum, catalyst/revisions, quality/cash flow, volume/entry confirmation, invalidation clarity, and reward/risk.

1. **SHOP — HOLD / protect winner, 12/16.** 0.862075 shares; live $150.98; average $144.09; value about $130.16; unrealized about +$5.94 (+4.78%). Prior close was above SMA20 $129.05 and SMA50 $120.73 with +21.43% 20-day and +56.65% 60-day momentum. Q2 growth/profit catalyst remains valid, but XLY was -0.86%, price was down 1.07%, and the position is roughly 39% of total account value. No add. Binding invalidation **$143.50**; targets **$160/$166**.
2. **BAC — HOLD / active resistance watch, 12/16.** 1.046363 shares; live $64.05; average $62.12; value about $67.02; unrealized about +$2.02 (+3.11%). Above SMA20 $62.15 and SMA50 $58.90 with +5.58% 20-day and +28.39% 60-day momentum. Recent earnings and financial trend remain supportive, but XLF was -0.19% and BAC was near resistance. No add. Binding invalidation **$61.40**; targets **$64.80/$66**.
3. **NESR — HOLD / active profit watch, 11/16.** 0.736516 shares; live $36.09; average $33.74; value about $26.58; unrealized about +$1.73 (+6.97%). Above SMA20 $28.47 and SMA50 $27.18 with +22.94% 20-day and +38.55% 60-day momentum. The earnings/revenue catalyst remains constructive, but XLE was -0.21%, the live spread was about $0.22, and price remained below the $36.60 first target. No add. Binding invalidation **$31.85**; targets **$36.60/$38**.
4. **AVGO — HOLD, 11/16.** 0.095750 shares; live $421.53; average $411.28; value about $40.36; unrealized about +$0.98 (+2.49%). Above SMA20 $395.12 and SMA50 $394.34 with +6.93% 20-day momentum and supportive XLK flow, but 60-day momentum remained -5.39%. Live price was below the $432.73 20-day high and not a fresh retest entry. Binding invalidation **$410**; targets **$440/$455**. No add.
5. **MA — HOLD / weakest, 10/16.** 0.113541 shares; live $557.83; average $572.48; value about $63.34; unrealized about -$1.66 (-2.56%). Prior close remained above SMA20 $556.12 and SMA50 $524.21, with +4.35% 20-day and +14.59% 60-day momentum and strong business quality. However, MA lagged BAC and XLF and traded down 0.64%. Binding invalidation **$550**; targets **$583/$600**. Exit/rotation review is mandatory if $550 breaks or score falls below 10; do not average down.

No holding breached its binding invalidation, scored below 10, or reached a target with a confirmed momentum stall. Therefore no trim or exit was justified at this snapshot.

## Fresh candidate scorecard

1. **NVDA — 13/16 (1/2/1/2/2/1/2/2), WATCH; no entry.** Live $222.586 (+2.34%), above SMA20 $207.80 and SMA50 $206.27, with +2.69% 20-day momentum but -7.74% 60-day momentum. Revenue and net income continue to expand sharply; verified earnings are due 2026-08-26 PM. The live move approached the $224.76 20-day high without a confirmed breakout-retest and was near event risk. Planned setup only after confirmation: entry/retest near $219, invalidation $211.50, targets $232/$240 (about 1.73R/2.80R). It could not replace MA because the entry tactic was unconfirmed and would add a third correlated technology/AI thesis alongside SHOP/AVGO exposure.
2. **JPM — 13/16 (1/2/2/2/2/0/2/2), WATCH; no entry.** Live $362.50 (+0.13%), above SMA20 $351.62 and SMA50 $335.52, with +5.58% 20-day and +20.72% 60-day momentum. Latest verified EPS was $6.14 versus $5.59 estimated; quarterly revenue/net income remained strong. However, XLF was negative, price was near the $363.12 20-day high, and no breakout-retest/volume confirmation occurred. Proposed confirmed-retest plan: entry $359.50, invalidation $353, targets $372/$379 (about 1.92R/3.00R). It was not materially superior enough to justify rotating MA while already holding BAC financial exposure.
3. **GOOGL — 9/16 (1/0/0/2/2/0/2/2), NO TRADE.** Live $344.225 (+0.12%), below SMA20 $348.23 and SMA50 $355.12; the daily trend and sector-relative momentum gate failed despite strong revenue/earnings quality and the recent verified Q2 beat. ATR14 was about $12.42. A hypothetical $344.25 entry / $335 invalidation / $360-$370 targets offers acceptable arithmetic, but it is not one of the policy-approved entry tactics while price is below both averages. Require trend repair and a confirmed retest before reconsideration.

The score threshold alone did not authorize an order. NVDA and JPM lacked the required entry confirmation, both created concentration concerns, no sixth holding was permitted, and neither offered a confirmed material improvement over the weakest valid holding after execution/thesis uncertainty.

## Action, review, and failures

- Equity orders reviewed: **0** — no proposed order survived the policy and entry-confirmation gates.
- Equity orders placed/canceled: **0/0**.
- Position changes: **0**.
- No broker tool failed. Web catalyst retrieval was incomplete for exact authoritative CPI release figures, so those figures were not guessed.

## Next triggers

- MA: exit/rotation review on a decisive **$550** break.
- AVGO: exit review below **$410**; do not chase strength.
- SHOP: protect **$143.50**, evaluate profit behavior at **$160**.
- BAC: evaluate rejection/acceptance at **$64.80**.
- NESR: evaluate acceptance at **$36.60** and avoid adding into its wide spread.
- Fresh entries: require a policy-labeled, confirmed retest and either available slot or a materially superior 13+ replacement for the weakest holding.

## Post-decision broker verification

- Fresh portfolio read: **$333.7211902404 account value**, **$327.5111902404 equity value**, **$6.21 cash**, and **$6.21 buying power**.
- Exact final equity deployment: **98.1392%**; exact final cash buffer: **1.8608%**.
- The same five quantities remained open and fully sellable, all with `intraday_quantity=0`: AVGO 0.095750, MA 0.113541, BAC 1.046363, SHOP 0.862075, and NESR 0.736516.
- Fresh independent order checks again returned zero `new`, `queued`, `confirmed`, `unconfirmed`, and `partially_filled` orders. No broker-side action or fill occurred during this scan.
